- Home
- NVAX vs HBI Comparison
NVAX vs HBI Comparison
Compare NVAX & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- HBI
- Stock Information
- Founded
- NVAX 1987
- HBI 1901
- Country
- NVAX United States
- HBI United States
- Employees
- NVAX N/A
- HBI N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- HBI Clothing/Shoe/Accessory Stores
- Sector
- NVAX Health Care
- HBI Consumer Discretionary
- Exchange
- NVAX Nasdaq
- HBI Nasdaq
- Market Cap
- NVAX 1.3B
- HBI 1.9B
- IPO Year
- NVAX 1995
- HBI 2006
- Fundamental
- Price
- NVAX $6.84
- HBI $4.63
- Analyst Decision
- NVAX Buy
- HBI Hold
- Analyst Count
- NVAX 5
- HBI 4
- Target Price
- NVAX $16.60
- HBI $5.75
- AVG Volume (30 Days)
- NVAX 4.9M
- HBI 4.5M
- Earning Date
- NVAX 08-07-2025
- HBI 08-07-2025
- Dividend Yield
- NVAX N/A
- HBI N/A
- EPS Growth
- NVAX N/A
- HBI N/A
- EPS
- NVAX 2.97
- HBI N/A
- Revenue
- NVAX $1,254,962,000.00
- HBI $3,522,911,000.00
- Revenue This Year
- NVAX $56.85
- HBI $0.50
- Revenue Next Year
- NVAX N/A
- HBI N/A
- P/E Ratio
- NVAX $2.30
- HBI N/A
- Revenue Growth
- NVAX 25.92
- HBI 0.65
- 52 Week Low
- NVAX $5.01
- HBI $4.02
- 52 Week High
- NVAX $17.81
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- NVAX 51.12
- HBI 45.90
- Support Level
- NVAX $6.54
- HBI $4.57
- Resistance Level
- NVAX $7.20
- HBI $4.80
- Average True Range (ATR)
- NVAX 0.28
- HBI 0.17
- MACD
- NVAX 0.06
- HBI 0.02
- Stochastic Oscillator
- NVAX 66.36
- HBI 58.71
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.